Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 28, 2018 16:05 ET | Source: Novavax, Inc.

Novavax to Participate at Two Upcoming Investor Conferences

GAITHERSBURG, Md., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced that Novavax will participate in the B. Riley FBR Annual Healthcare Conference and the Citi 13th...
August 08, 2018 16:05 ET | Source: Novavax, Inc.

Novavax Reports Second Quarter 2018 Financial Results

Novavax Delivers on Key Milestones Supporting its 2018 Objectives Company to Host Conference Call Today at 4:30 pm ET GAITHERSBURG, Md., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:...
August 01, 2018 16:05 ET | Source: Novavax, Inc.

Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 8, 2018

GAITHERSBURG, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its second quarter 2018 financial and operating results following the close of U.S....
June 13, 2018 17:05 ET | Source: Novavax, Inc.

New England Journal of Medicine Publishes Novavax’ NanoFlu Clinical Trial Data

NanoFluTM Phase 1/2 trial data published in a peer-reviewed letter to the editor in The New England Journal of MedicineNanoFlu demonstrates significantly improved immune responses against a panel of...
May 09, 2018 16:05 ET | Source: Novavax, Inc.

Novavax Reports First Quarter 2018 Financial Results

GAITHERSBURG, Md., May 09, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced its financial results for the first quarter ended March 31, 2018. First Quarter and Subsequent...
May 07, 2018 07:00 ET | Source: Novavax, Inc.

Novavax Reaches Significant Enrollment Milestone in the Prepare(TM) Phase 3 Trial of its RSV F Vaccine

Prepare trial is assessing the efficacy of Novavax’ RSV F Vaccine for infants via maternal immunizationEnrollment of ~4,600 participants enables initiation of interim efficacy analysisTopline efficacy...
May 02, 2018 16:05 ET | Source: Novavax, Inc.

Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 9, 2018

GAITHERSBURG, Md., May 02, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its first quarter 2018 financial and operating results following the close of U.S....
April 16, 2018 16:05 ET | Source: Novavax, Inc.

Novavax Announces Closing of Public Offering

GAITHERSBURG, Md., April 16, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today...
April 11, 2018 20:50 ET | Source: Novavax, Inc.

Novavax Prices Public Offering of Common Stock

GAITHERSBURG, Md., April 11, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today...
April 11, 2018 16:01 ET | Source: Novavax, Inc.

Novavax Announces Proposed Public Offering of Common Stock

GAITHERSBURG, Md., April 11, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today...